Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr

Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr

By: IPP Bureau

Last updated : November 03, 2023 8:37 am



Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023


Lincoln Pharmaceuticals Limited has reported Consolidated financial results for the period ended September 30, 2023.

Lincoln Pharmaceuticals has posted net profit of Rs. 27.65 crores for the period ended September 30, 2023 as against net profit of Rs. 19.01 crores for the period ended June 30, 2023. The company posted net profit of Rs.23.71 crores for the period ended September 30, 2022.

Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023 as compared to Rs. 143.31 crores during the period ended June 30, 2023. The company reported total income of Rs.146.33 crores during the period ended September 30, 2022.

For the Half Year ended September 30, 2023, Lincoln Pharmaceuticals has reported total income of Rs.307.99 crores as compared to Rs.276.29 crores during the 6 months period ended September 30, 2022.

The company has posted net profit of Rs.46.66 crores for the 6 months period ended September 30, 2023 as against net profit of Rs.38.72 crores for the 6 months period ended September 30, 2022.

Lincoln Pharmaceuticals Limited

First Published : November 03, 2023 12:00 am